Europe Federated Learning In Healthcare Market Size, Share & Trends Analysis Report By Deployment Mode (On-Premise and Cloud-Based) By End Use, By Application, By Country and Growth Forecast, 2025 - 2032

The Europe Federated Learning In Healthcare Market would witness market growth of 15.2% CAGR during the forecast period (2025-2032).

The Germany market dominated the Europe Federated Learning In Healthcare Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $6,367.5 Thousands by 2032. The UK market is exhibiting a CAGR of 14.2% during (2025 - 2032). Additionally, The France market would experience a CAGR of 16.1% during (2025 - 2032).

Federated learning allows healthcare providers to build models that predict disease progression, hospital readmissions, or treatment responses by analyzing electronic health records (EHRs) from various facilities. These models can identify patterns in patient data, such as risk factors for chronic diseases like diabetes or hypertension, without compromising individual privacy. Additionally, federated learning is applied in genomics research, where institutions collaborate to analyze genetic data for personalized medicine.

Federated learning also supports drug discovery and development. Pharmaceutical companies and research institutions can use FL to analyze clinical trial data distributed across multiple sites, accelerating the identification of promising drug candidates. This collaborative approach enhances the generalizability of findings, as models are trained on diverse patient cohorts without data sharing. Furthermore, federated learning is employed in wearable devices and remote patient monitoring, enabling real-time analysis of health metrics like heart rate or glucose levels while keeping data on users’ devices.

In healthcare, federated learning (FL) is gaining significant traction across Europe as governments increasingly invest in digital transformation, data security, and AI-driven medical solutions. Furthermore, in Italy, the healthcare sector is seeing a notable increase in ICT expenditure, reaching $1.98 billion in 2022, a 7% rise from 2021. Moreover, in the United Kingdom, the government’s £30 million investment in innovative technology for the NHS underscores a strategic push toward digitization and AI adoption. With the NHS being one of the world’s most comprehensive publicly funded health systems, data security and interoperability are paramount. The healthcare sector’s enormous economic footprint in Germany—accounting for EUR 775 billion or roughly 12% of GDP—demonstrates its critical role in the national economy. With a gross value added of EUR 439.6 billion in 2022, Germany’s healthcare industry is among the most advanced and well-funded in Europe. In summary, the increasing digital health investments and structural reforms in Italy, the UK, and Germany are accelerating the market's growth.

Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End Use, the market is segmented into Hospitals & Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Institutions, and Government & Regulatory Bodies. Based on Application, the market is segmented into Drug Discovery & Development, Medical Imaging, Electronic Health Records (EHR) Analysis, Remote Patient Monitoring, and Clinical Trials & Other Application. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• GE HealthCare Technologies, Inc.
• Google LLC (Alphabet Inc.)
• IBM Corporation
• Microsoft Corporation
• Siemens Healthineers AG (Siemens AG)
• Medtronic PLC
• NVIDIA Corporation
• Intel Corporation
• Health Catalyst, Inc.
• Owkin

Europe Federated Learning In Healthcare Market Report Segmentation

By Deployment Mode

• On-Premise
• Cloud-Based

By End Use

• Hospitals & Healthcare Providers
• Pharmaceutical & Biotechnology Companies
• Research Institutions
• Government & Regulatory Bodies

By Application

• Drug Discovery & Development
• Medical Imaging
• Electronic Health Records (EHR) Analysis
• Remote Patient Monitoring
• Clinical Trials & Other Application

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe